Shannon Hader
Overview
Explore the profile of Shannon Hader including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuniga J, Prachniak C, Policek N, Magula N, Gandhi A, Anderson J, et al.
Lancet HIV
. 2024 Jul;
11(9):e607-e648.
PMID: 39043198
No abstract available.
2.
Ussery F, Bachanas P, Alwano M, Lebelonyane R, Block L, Wirth K, et al.
J Acquir Immune Defic Syndr
. 2022 May;
91(1):9-16.
PMID: 35537094
Background And Setting: The Botswana Combination Prevention Project demonstrated a 30% reduction in community HIV incidence through expanded HIV testing, enhanced linkage to care, and universal antiretroviral treatment and exceeded...
3.
Lebelonyane R, Bachanas P, Block L, Ussery F, Alwano M, Marukutira T, et al.
PLoS One
. 2021 Aug;
16(8):e0255227.
PMID: 34375343
Background: Increasing HIV treatment coverage is crucial to reducing population-level HIV incidence. Methods: The Botswana Combination Prevention Project (BCPP) was a community randomized trial examining the impact of multiple prevention...
4.
De Lay P, Benzaken A, Abdool Karim Q, Aliyu S, Amole C, Ayala G, et al.
PLoS Med
. 2021 Jun;
18(6):e1003649.
PMID: 34101728
Paul De Lay and co-authors introduce a Collection on the design of targets for ending the AIDS epidemic.
5.
6.
Bachanas P, Alwano M, Lebelonyane R, Block L, Behel S, Raizes E, et al.
PLoS One
. 2021 Apr;
16(4):e0250211.
PMID: 33882092
Introduction: The scale-up of Universal Test and Treat has resulted in reductions in HIV morbidity, mortality and incidence. However, healthcare system and personal challenges have impacted the levels of treatment...
7.
Roberts T, Sahu S, Malar J, Abdullaev T, Vandevelde W, Pillay Y, et al.
J Int AIDS Soc
. 2021 Mar;
24(4):e25696.
PMID: 33787058
Introduction: Until COVID-19, tuberculosis (TB) was the leading infectious disease killer globally, disproportionally affecting people with HIV. The COVID-19 pandemic is threatening the gains made in the fight against both...
8.
Nkengasong J, Mbopi-Keou F, Peeling R, Yao K, Zeh C, Schneidman M, et al.
Lancet Infect Dis
. 2018 Jul;
18(11):e362-e367.
PMID: 29980383
The Maputo Declaration of 2008 advocated for commitment from global stakeholders and national governments to prioritise support and harmonisation of laboratory systems through development of comprehensive national laboratory strategies and...
9.
Raizes E, Hader S, Birx D
J Infect Dis
. 2017 Dec;
216(suppl_9):S805-S807.
PMID: 29206999
The US President's Emergency Plan for AIDS Relief (PEPFAR) supports aggressive scale-up of antiretroviral therapy (ART) in high-burden countries and across all genders and populations at risk toward global human...
10.
Gamble T, Branson B, Donnell D, Hall H, King G, Cutler B, et al.
Clin Trials
. 2017 Jun;
14(4):322-332.
PMID: 28627929
Background/Aims HIV continues to be a major public health threat in the United States, and mathematical modeling has demonstrated that the universal effective use of antiretroviral therapy among all HIV-positive...